Penserra Capital Management LLC Annexon, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$11.49 - $22.0 $10,053 - $19,250	-875 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.35 - $23.4 $81 - $117	5 Added 0.57%	875 $16,000
Q2 2021 Aug 12, 2021	BUY	$17.81 - $27.48 $178 - $274	10 Added 1.16%	870 $19,000
Q1 2021 May 13, 2021	SELL	$22.0 - $35.01 $550 - $875	-25 Reduced 2.82%	860 $23,000
Q4 2020 Feb 12, 2021	BUY	$20.81 - $30.55 $18,416 - $27,036	885 New	885 $22,000

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.